MMP9 and encephalomyelitis: JNJ0966, GS-5745, two chemotherapy drugs, were selective inhibitors regarding matrix metalloproteinase-9 (MMP-9), had shown prospective view in treatment of encephalomyelitis, ulcerative colitis and gastric cancer [11, 12].